Cerner and Lumeris sign a 10-year deal to launch a new EHR-agnostic tool aimed to improve physician-patient encounters and population health. The EHR giant and the care managed services operator Lumeris signed a decade-long partnership deal to streamline healthcare data exchange, reimbursement cycles via a new health IT product.
This collaboration will also get Cerner $266 million shares in Essence Group Holding, a Lumeris parent company, according to the financial filing. Lumeris also runs EGH’s 65,000 member healthcare plan in Illinois and Missouri.
Maestro Advantage, a new technology, is a result of this new partnership. The technology aims at value-based payment arrangements like Medicare Advantage and provider-sponsored health plans.
The new platform aims to help health systems in improving routine lengthy claim processing, the hassle of dealing with reimbursement cycles, easing the process of sharing data and records, and also improving patient experience and patient outcomes as a whole.
Chairman of Kleiner Perkins and a Lumeris board member, John Doerr said, “The United States health care system’s transition to value-based care has been impeded by disjointed technology, cumbersome processes, misaligned incentives and inadequate management of clinical and financial outcomes. Maestro Advantage lowers the barriers to data transparency and sharing and empowers physicians and health systems,” he added. “However, we know technology alone is not sufficient. Maestro Advantage is an innovative model with supporting processes and expertise to aid long-term success in value-based care arrangements.”
According to Cerner, initial implementations of Maestro Advantage are expected to go live later in 2018. On the other hand, the broad market deployments are scheduled to begin in 2019.
Cerner CEO Brent Shafer also said in a statement, “By using data to reduce or eliminate unnecessary costs and ineffective transitions of care, providing doctors and their patients a more complete view of their medical history and a health plan that consistently receives high-quality scores from CMS, this collaboration with Lumeris aligns well with our mission and illustrates the potential of Cerner technology to positively impact healthcare economics and outcomes in deeper, more impactful ways than before.”
This new strategic partnership will see Lumeris adopting Cerner’s HealthIntent population health technology. The executives from Cerner and Lumeris will work together on business development, client delivery and innovation for Maestro Advantage.
